Conditions We Support
.jpg?width=1536&height=1024&name=Untitled%20design%20(57).jpg)
Diffuse Large B-Cell Lymphoma (DLBCL)
We support adults who are newly diagnosed with diffuse large B-cell lymphoma and currently receiving R-CHOP as first-line therapy. Early treatment decisions and timing can feel overwhelming, especially when navigating next steps.
Our role is to help you understand where you are in the process, what questions may be important to ask, and how to feel more prepared when speaking with your oncology team.
.jpg?width=1536&height=1024&name=Untitled%20design%20(58).jpg)
Multiple Myeloma
We support adults who are newly diagnosed with multiple myeloma and receiving bispecific antibody therapy as first-line treatment. As treatment progresses, many patients and families seek clarity around timing, options, and what comes next.
Through a private Zoom conversation, we help you talk through your situation, understand general pathways, and feel more confident navigating ongoing care discussions.
Frequently asked questions
Is this a medical service or second opinion?
Our conversations are informational, educational and supportive, designed to help you better understand your situation and prepare for discussions with your doctor.
Who will I be speaking with on the Zoom call?
You will speak with a person who has experience supporting other patients as an advocate. This person focuses on listening, understanding your situation, and helping you and your loved ones think through timing and next steps. We do not replace your oncologist.
Is there any cost to speak with someone?
No. There is no cost and no obligation to continue beyond the conversation.
Do I need a referral from my doctor?
No referral is required. You can contact us directly because this conversation is complementary to your consultations with your doctor.
Is this only for certain diagnoses or treatments?
Yes. We currently support:
-
Adults with Non-Hodgkins Lymphoma (DLBCL)
-
Adults with Multiple Myeloma
This helps us keep conversations focused and relevant.
